Spruce biosciences to participate in the oppenheimer 33rd annual healthcare conference

South san francisco, calif.--(business wire)---- $sprb--spruce biosciences, inc. (nasdaq: sprb), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that javier szwarcberg, m.d., m.p.h., chief executive officer, will present at the oppenheimer 33rd annual healthcare conference on march 14, 2023 at 2:40 pm et. interested parties can access the live webcast here.
SPRB Ratings Summary
SPRB Quant Ranking